ConductScience.org, home

Paper24687169

Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.

Lexis CP and 23 others. JAMA, 2014. Cited by 148 papers, by iCite.

Cite this record

ConductScience Library. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. Papers, record 24687169. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24687169

Download JSON
Disease
heart failure311 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
PubMed
Journal
JAMA
PubMed
Year
2014
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
148
iCite
Relative citation ratio, by iCite
4.68
iCite
Revised in PubMed
2026-05-18
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lexis CPChris P H
2van der Horst ICIwan C C
3Lipsic EErik
4Wieringa WGWouter G
5de Boer RARudolf A
6van den Heuvel AFAd F M
7van der Werf HWHindrik W
8Schurer RARemco A J
9Pundziute GGabija
10Tan ESEng S
11Nieuwland WWybe
12Willemsen HMHendrik M
13Dorhout BBernard
14Molmans BHBarbara H W
15van der Horst-Schrivers ANAnouk N A
16Wolffenbuttel BHBruce H R
17ter Horst GJGert J
18van Rossum ACAlbert C
19Tijssen JGJan G P
20Hillege HLHans L

Source PubMed

See all 24 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypoglycemic AgentsMajor topic
MetforminMajor topic
Myocardial InfarctionMajor topic
Ventricular Dysfunction, LeftMajor topic
Ventricular Function, LeftMajor topic
Aged
Double-Blind Method
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Percutaneous Coronary Intervention
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01217307Metformin to Reduce Heart Failure After Myocardial InfarctionDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in24736756Acute coronary syndromes: Metformin not associated with improved left ventricular function after STEMI in patients without diabetes mellitus.https://conductscience.org/library/papers/24736756PubMed
Comment in25617933Study answers long-standing question about metformin after heart attack.https://conductscience.org/library/papers/25617933PubMed

Download CSV of comments and corrections

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.

PMIDTitleJournalYearIn PapersSource
42920579Sex-dependent transcriptional and imaging responses to metformin in young-adult mice with SuHx-induced pulmonary arterial hypertension.Front Cardiovasc Med2026https://conductscience.org/library/papers/42920579PubMed
42351790AMPK Signalling in Heart Failure: From Metabolic Sensor to Context-Dependent Therapeutic Target.Biomedicines2026https://conductscience.org/library/papers/42351790PubMed
42156933Sex differences in cardiac structure and function following ST-segment elevation myocardial infarction.Sci Rep2026https://conductscience.org/library/papers/42156933PubMed
42047732Metformin as a potential therapeutic agent in broken heart syndrome: Targeting AMPK-dependent cardio-protection and microvascular function.Mol Biol Rep2026https://conductscience.org/library/papers/42047732PubMed
41704279Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies.Front Pharmacol2026https://conductscience.org/library/papers/41704279PubMed
41090739Myocardial Ischemia/Reperfusion Injury: Molecular Insights, Forensic Perspectives, and Therapeutic Horizons.Cells2025https://conductscience.org/library/papers/41090739PubMed
40978514The immune checkpoint TIM-3/HMGB-1 axis in myocardial infarction.NPJ Cardiovasc Health2025https://conductscience.org/library/papers/40978514PubMed
40582648Emerging uncertainty on the anti-aging potential of metformin.Ageing Res Rev2025https://conductscience.org/library/papers/40582648PubMed
40423634Type 2 Diabetes Mellitus: A Metabolic Model of Accelerated Aging - Multi-Organ Mechanisms and Intervention Approaches.Aging Dis2025https://conductscience.org/library/papers/40423634PubMed
39685849Exogenous Ketones in Cardiovascular Disease and Diabetes: From Bench to Bedside.J Clin Med2024https://conductscience.org/library/papers/39685849PubMed
39235508Multi-omics analysis of the lipid-regulating effects of metformin in a glucose concentration-dependent manner in macrophage-derived foam cells.Cell Biochem Biophys2024https://conductscience.org/library/papers/39235508PubMed
39155333Association of fibrotic markers with diastolic function after STEMI.Sci Rep2024https://conductscience.org/library/papers/39155333PubMed
38094689Sodium Thiosulfate in Acute Myocardial Infarction: A Randomized Clinical Trial.JACC Basic Transl Sci2023https://conductscience.org/library/papers/38094689PubMed
38057783Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients.Cardiovasc Diabetol2023https://conductscience.org/library/papers/38057783PubMed
36806755Higher mitochondrial DNA copy number is associated with metformin-induced weight loss.Commun Med (Lond)2023https://conductscience.org/library/papers/36806755PubMed
36747244Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.Cardiovasc Diabetol2023https://conductscience.org/library/papers/36747244PubMed
36690932Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction.BMC Cardiovasc Disord2023https://conductscience.org/library/papers/36690932PubMed
36211585Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies.Front Cardiovasc Med2022https://conductscience.org/library/papers/36211585PubMed
36052760Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.J Cell Mol Med2022https://conductscience.org/library/papers/36052760PubMed
35638331Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease.J Diabetes Investig2022https://conductscience.org/library/papers/35638331PubMed

See all 80 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
METFORMINCHEMBL1431Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1431

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24687169

GET https://conductscience.org/api/papers/v1/24687169/authors?page=2